invivodata Offering COA Gap Analysis Service at Industry Events
Reducing Risk is Key Benefit for Over 50 Biopharmaceutical Companies To Date
(PRWeb May 31, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9560503.htm

Reducing Risk is Key Benefit for Over 50 Biopharmaceutical Companies To Date
(PRWeb May 31, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9560503.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
